Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines
- 1 November 2011
- journal article
- Published by Elsevier BV in Cytokine
- Vol. 56 (2), 231-238
- https://doi.org/10.1016/j.cyto.2011.06.004
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (30800997 and 30930085)
- National Key Basic Research Program of China (2007CB512402)
This publication has 37 references indexed in Scilit:
- The aging of the immune systemTransplant International, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Soluble CD276 (B7‐H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serumImmunology, 2008
- Appropriate calibration curve fitting in ligand binding assaysThe AAPS Journal, 2007
- PD‐L1 expression analysis in gastric carcinoma tissue and blocking of tumor‐associated PD‐L1 signaling by two functional monoclonal antibodiesTissue Antigens, 2006
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- Interferon regulatory factor‐1 is prerequisite to the constitutive expression and IFN‐γ‐induced upregulation of B7‐H1 (CD274)FEBS Letters, 2006
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritisExperimental & Molecular Medicine, 2004
- Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial CellsMicrocirculation, 2002